[{"NetIncomeLoss_1_Q2_USD":-56273000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":17171000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":49063298.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":49204425.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":208216000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-87203000.0,"Depreciation_2_Q2_USD":518000.0,"Depreciation_1_Q2_USD":300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":820286.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":133000.0,"AssetsCurrent_0_Q2_USD":1091420000.0,"OperatingLeaseExpense_2_Q2_USD":1000000.0,"OperatingLeaseExpense_1_Q2_USD":600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5599212.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":8398000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1831000.0,"IncomeTaxesPaidNet_2_Q2_USD":1000.0,"CommonStockSharesIssued_0_Q2_shares":49391738.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":651759000.0,"AmortizationOfLeasedAsset_2_Q2_USD":965000.0,"Assets_0_Q2_USD":1102920000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":22.24,"ShareBasedCompensation_2_Q2_USD":30573000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":37162000.0,"MarketableSecuritiesCurrent_0_Q2_USD":651759000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":6502000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1577000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":85913000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":44650000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":46.02,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":6997000.0,"EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_0_Q2_shares":228156.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":2100703.0,"ProceedsFromStockPlans_2_Q2_USD":19020000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.804,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.799,"CommonStockValue_0_Q2_USD":5000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-2861000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6269000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":19020000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":1077360000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-91985000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-56295000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1612000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0105,"OtherAssetsNoncurrent_0_Q2_USD":2021000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":426047000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3518000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1439453000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-208000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-22000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":169434000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9590097.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":56.05,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"StockholdersEquity_0_Q2_USD":1067507000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":874000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":651757000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-2771000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5406931.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-371953000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-126252000.0,"CommonStockSharesOutstanding_0_Q2_shares":49391738.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":255763000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1964000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":135000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13295000.0,"OtherLiabilitiesCurrent_0_Q2_USD":84000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-58069000.0,"LiabilitiesCurrent_0_Q2_USD":31895000.0,"AccountsPayableCurrent_0_Q2_USD":7088000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":13614000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":119126000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":427922000.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.071,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":691537.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":943000.0,"OperatingLeasePayments_2_Q2_USD":1000000.0,"OperatingLeasePayments_1_Q2_USD":600000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3210000.0,"NetIncomeLoss_2_Q2_USD":-91777000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3589000.0,"OtherOperatingIncome_1_Q2_USD":384000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.14,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3544000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":77.86,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":48.45,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":495000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":5589000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":30369000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":5164000.0,"OperatingIncomeLoss_2_Q2_USD":-92706000.0,"OperatingIncomeLoss_1_Q2_USD":-56657000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":3574211.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":113.61,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.87,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1102920000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5727000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":30573000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":13295000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":130900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":512531.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":5174000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2984000.0,"OperatingExpenses_2_Q2_USD":123075000.0,"OperatingExpenses_1_Q2_USD":61821000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":5719000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":26.14,"OtherOperatingIncome_2_Q2_USD":929000.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]